Work

Patient-reported outcome planning and reporting in CAR-T and CD3xCD20 bispecific antibody trials for relapsed/refractory lymphoma: A cross-sectional analysis (2017–2025).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e19107

Authors: Canan Dilay Dirican, Aqsa Zoey Sorathia, Raj Nandan Chennuri, Bugra Zengin, Swapna Gangasani, Jeril Lasington, Michael Maroules

Institutions: New York Medical College, St. Mary's Hospital, St. Joseph’s University Medical Center, Hamilton Medical Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162692369

Cites:

Cited by:

Related to: